Microvascular Dysfunction


Women’s IschemiA TReatment Reduces Events In Non-ObstRuctive CAD

WARRIOR is a four-year, multicenter clinical trial to determine whether aggressive treatment of nonobstructive coronary artery disease (CAD) with medication and lifestyle modification will reduce the likelihood of major adverse events such as stroke, heart attack, heart failure, hospitalization, and death.

WARRIOR on ClinicalTrials.gov: clinicaltrials.gov


Email: warrior@medicine.ufl.edu

Phone: (352) 273-7901

Interested in more information? Click here for the WARRIOR Website

Qualitative MVA

Qualitative interviews to understand the patient experience of Microvascular Angina (MVA)

The purpose of this research study is to get feedback on a new questionnaire developed for patients with microvascular angina (MVA). Specifically, we would like to know if the questionnaire asks questions about things that are important to patients with MVA.

Sanofi ACT

ACT is a randomized, placebo-controlled study to assess the effects of an investigational drug called SAR407899 in patients with microvascular angina and/or persistent stable angina despite angiographically successful elective percutaneous coronary intervention.

ACT on clinicaltrials.gov

Please contact our Clinical Trials Office for information: (352) 273-8933  ufcardiovascularct@medicine.ufl.edu